Oct
2026
Fiera Milano, Italy
Visit us
stand 1B94, Excipients&Fine Chemicals
Croda Pharma
Exhibitor at CPHI Milan 2026
About Us
Categories
-
Country/Region:United Kingdom
-
On CPHI since:2015
-
Certificates:2
-
Employees:1000 - 4999
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 1B94, Excipients&Fine Chemicals
Products Featured at CPHI Milan 2026
-
Product Adjuvant Systems for Vaccines
We enable next-generation vaccine development through a diverse portfolio of world-leading vaccine adjuvants, immunomodulators and adjuvant formulations.
We passionately develop new adjuvant technologies and partner to develop the vaccines of tomorrow.
Our extensive expertise in immunology and fo... -
Product Bioprocessing solutions and excipients for protein therapeutic formulations
From excipients for protein therapeutic formulations, to innovating solutions for bioprocessing, we have decades of experience in protein delivery. TALK TO US about our latest launches: Virodex™ detergent range, a sustainable alternative to Triton™ X-100 for viral inactivation and cell lysis. Plus, Tween... -
Product Excipients for Consumer Health
Croda Pharma's Consumer Health offering combines our technical expertise with regulatory knowledge to help our customers market innovative products with consumer relevant claims, alongside supporting formulation development challenges within the Consumer Health market.
Our excipient solutions support ... -
Product High purity excipients for small molecule delivery
We offer high purity, multi-compendial, pharmaceutical excipients for small molecule drug delivery. Our portfolio of high purity excipient products and speciality chemistries solve formulation challenges and enhance drug delivery across a variety of administration routes and dosage forms. We are market le... -
Product Nucleic Acid Delivery for Vaccines and Next-Gen Therapeutics
Avanti Polar Lipids, part of Croda Pharma, develops innovative lipids of unparalleled purity to solve the stability and delivery issues associated with mRNA for use in vaccines and next-generation therapeutics.
We develop and manufacture highly specialised lipids used in Lipid Nanoparticle (LNP) deliv...
Croda pharma Resources (1)
-
Brochure Addressing the challenges of vaccine formulation
To this day, our focus has been to successfully develop, manufacture and market high-quality adjuvants for our pharmaceutical customers. This heritage makes our vaccine adjuvants unique in the industry. A heritage we are proud of.
Our industry-leading, Alhydrogel®, Adju-Phos® and Quil-A® are widely recognised in the vaccine industry for their unmatched track record when it comes to a proven history of safe and effective use.




